MDS expands services in Europe
Pennsylvania, USA-based MDS Pharma Services, a provider of drug discovery and development solutions, has announced the expansion of its Development & Regulatory Services business in Europe. The US firm will now offer full-service DRS consulting services to support development of new drugs and biopharmaceutical products for clients in Europe.
The European DRS organization will also be fully integrated with consultants in the USA and Canada to provide product development consulting, program management and regulatoryplll affairs services for new drugs and biopharmaceutical products.
"This expansion in Europe will greatly broaden our consulting capabilities in development and regulatory services," said MDS president David Spaight. "We will now be able to provide expertise to support our biotechnology and Asian pharmaceutical clients in the process of commercializing their products in North American and European markets," he added.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze